| Literature DB >> 34768973 |
Valentin Nastasa1, Aurelian-Sorin Pasca1, Razvan-Nicolae Malancus1, Andra-Cristina Bostanaru1, Luminita-Iuliana Ailincai1, Elena-Laura Ursu2, Ana-Lavinia Vasiliu2, Bogdan Minea3, Eugen Hnatiuc1, Mihai Mares1.
Abstract
Non-thermal plasma activated water (PAW) has recently emerged as a powerful antimicrobial agent. Despite numerous potential bio-medical applications, studies concerning toxicity in live animals, especially after long-term exposure, are scarce. Our study aimed to assess the effects of long-term watering with PAW on the health of CD1 mice. PAW was prepared from distilled water with a GlidArc reactor according to a previously published protocol. The pH was 2.78. The mice received PAW (experimental group) or tap water (control group) daily for 90 days as the sole water source. After 90 days, the following investigations were performed on the euthanatized animals: gross necropsy, teeth mineral composition, histopathology, immunohistochemistry, hematology, blood biochemistry, methemoglobin level and cytokine profile. Mice tolerated PAW very well and no adverse effects were observed during the entire period of the experiment. Histopathological examination of the organs and tissues did not reveal any structural changes. Moreover, the expression of proliferation markers PCNA and Ki67 has not been identified in the epithelium of the upper digestive tract, indicating the absence of any pre- or neoplastic transformations. The results of our study demonstrated that long-term exposure to PAW caused no toxic effects and could be used as oral antiseptic solution in dental medicine.Entities:
Keywords: GlidArc reactor; cytokine profile; immunohistochemistry; non-thermal plasma activated water (PAW); toxicity in mice
Mesh:
Substances:
Year: 2021 PMID: 34768973 PMCID: PMC8583710 DOI: 10.3390/ijms222111534
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Teeth composition—% atoms.
| Minerals | Control(Mean ± SD) | PAW(Mean ± SD) |
|---|---|---|
| Carbon (C) | 66.19 ± 6.04 | 58.39 ± 7.85 |
| Nitrogen (N) | 10.28 ± 1.69 | 8.37 ± 1.41 |
| Oxygen (O) | 19.70 ± 4.34 | 24.13 ± 5.10 |
| Fluorine (F) | 0.14 ± 0.06 | 0.20 ± 0.16 |
| Sodium (Na) | 0.11 ± 0.07 | 0.18 ± 0.06 |
| Magnesium (Mg) | 0.16 ± 0.11 | 0.29 ± 0.15 |
| Aluminum (Al) | 0.05 ± 0.03 | 0.12 ± 0.07 |
| Silicon (Si) | 0.05 ± 0.02 | 0.05 ± 0.01 |
| Phosphorus (P) | 1.52 ± 1.18 | 3.39 ± 1.59 |
| Chlorine (Cl) | 0.00 ± 0.00 | 0.01 ± 0.01 |
| * Potassium (K) | 0.02 ± 0.01 | 0.06 ± 0.02 |
| Calcium (Ca) | 2.07 ± 1.57 | 4.75 ± 2.19 |
The asterisk (*) marks statistically significant differences.
Figure 1Tooth surface micro-morphology (SEM): (a) mouse from the control group; (b) mouse from the PAW treated group.
Figure 2AFM topography of teeth surface: (a) mouse from the control group; (b) mouse from the PAW treated group.
The absolute and relative weight of the essential organs.
| ORGAN | Control (Mean ± SD) | PAW (Mean ± SD) | ||
|---|---|---|---|---|
| Absolute (g) | Relative (%) | Absolute (g) | Relative (%) | |
| Heart | 0.18 ± 0.02 | 0.49 ± 0.04 | 0.17 ± 0.03 | 0.49 ± 0.08 |
| * Spleen | 0.16 ± 0.03 | 0.43 ± 0.04 | 0.13 ± 0.02 | 0.36 ± 0.03 |
| Liver | 1.45 ± 0.01 | 3.96 ± 0.37 | 1.33 ± 0.14 | 3.87 ± 0.31 |
| Kidneys | 0.45 ± 0.08 | 1.22 ± 0.12 | 0.39 ± 0.05 | 1.14 ± 0.10 |
| Brain | 0.49 ± 0.01 | 1.34 ± 0.15 | 0.50 ± 0.04 | 1.43 ± 0.11 |
| Bodyweight | 36.81 ± 4.95 | 34.43 ± 3.15 | ||
The asterisk (*) marks statistically significant differences.
Figure 3Tissue sections (Masson’s trichrome staining) of: (a) tongue, (b) esophagus, (c) keratinized gastric mucosa, (d) spleen.
Figure 4Immunohistochemistry—signals of Ki-67 and PCNA proliferation markers: (a) tongue mucosa—Ki-67, (b) tongue mucosa—PCNA, (c) esophagus mucosa—Ki-67, (d) esophagus mucosa—PCNA, (e) gastric keratinized mucosa—Ki-67, (f) gastric keratinized mucosa—PCNA.
Hematological parameters.
| Parameter | Control | PAW |
|---|---|---|
| RBC (1012/L) | 9.39 ± 0.55 | 9.22 ± 1.20 |
| HGB (g/dL) | 14.12 ± 0.93 | 13.05 ± 2.00 |
| HCT (%) | 45.48 ± 3.66 | 44.19 ± 7.26 |
| MCV (fl) | 48.00 ± 3.33 | 47.80 ± 4.96 |
| MCH (pg) | 14.64 ± 0.83 | 14.28 ± 0.91 |
| MCHC (g/dL) | 31.84 ± 2.62 | 31.64 ± 2.40 |
| RDWc (%) | 18.90 ± 1.55 | 18.81 ± 1.19 |
| RDWs (%) | 35.56 ± 6.73 | 33.83 ± 7.48 |
| PLT (109/L) | 367.10 ± 147.10 | 368.70 ± 118.10 |
| PCT (%) | 0.35 ± 0.05 | 0.32 ± 0.93 |
| MPV (fl) | 6.47 ± 0.26 | 6.66 ± 0.42 |
| PDWc (%) | 28.30 ± 1.45 | 29.10 ± 2.11 |
| PDWs (fl) | 7.84 ± 0.79 | 7.84 ± 0.87 |
| WBC (109/L) | 3.59 ± 0.82 | 3.77 ± 1.37 |
| NEU (109/L) | 0.36 ± 0.07 | 0.34 ± 0.10 |
| LIMF (109/L) | 2.94 ± 0.76 | 3.32 ± 1.22 |
| MONO (109/L) | 0.11 ± 0.02 | 0.12 ± 0.05 |
| EOS (109/L) | <min | <min |
| BASO (109/L) | <min | <min |
| NE (%) | 11.94 ± 2.84 | 10.80 ± 1.88 |
| LIMF (%) | 84.61 ± 3.76 | 85.12 ± 2.87 |
| MONO (%) | 3.60 ± 0.92 | 3.27 ± 0.99 |
| EOS (%) | - | - |
| BASO (%) | - | - |
Blood biochemical parameters.
| Parameter | Control | PAW |
|---|---|---|
| BUN (mg/dL) | 27.20 ± 5.59 | 29.90 ± 6.36 |
| GLU (mg/dL) | 137.50 ± 30.28 | 142.90 ± 11.97 |
| ALP/ALK (U/L) | 126.60 ± 20.44 | 135.10 ± 15.41 |
| GPT/ALT (U/L) | 21.10 ± 8.27 | 20.40 ± 4.97 |
| T-PRO (g/dL) | 5.25 ± 0.46 | 5.15 ± 0.69 |
| CREAT (mg/dL) | 0.96 ± 0.18 | 0.94 ± 0.20 |
Cytokine levels in CD1 mice.
| Cytokine | Control | PAW |
|---|---|---|
| IL-1a | 4.17 ± 0.71 | 3.54 ± 0.37 |
| IL-1b | <min | <min |
| IL-2 | 3.20 ± 0.01 | 2.67 ± 5.98 |
| IL-3 | 3.04 ± 0.61 | 2.17 ± 0.46 |
| IL-4 | 0.78 ± 0.49 | <min |
| IL-5 | 3.68 ± 0.76 | 1.92 ± 1.19 |
| IL-6 | 2.94 ± 0.26 | 2.30 ± 0.39 |
| IL-9 | 13.45 ± 2.5 | 6.89 ± 6.33 |
| IL-10 | 44.40 ± 27.65 | 15.25 ± 4.91 |
| IL-12 (p40) | 274.06 ± 46.64 | 214.86 ± 18.95 |
| IL-12 (p70) | 82.91 ± 13.87 | 60.61 ± 7.65 |
| IL-13 | 35.62 ± 10.56 | 60.61 ± 30.20 |
| IL-17A | 51.32 ± 16.76 | 12.78 ± 16.19 |
| IL-17F | 0.36 ± 0.32 | 0.29 ± 0.32 |
| IL-21 | <min | <min |
| IL-22 | 1.29 ± 0.64 | 1.71 ± 0.52 |
| IL-23 (p19) | 4.10 ± 4.30 | 2.55 ± 2.70 |
| IL-25 | 2.59 ± 1.53 | 0.53 ± 0.26. |
| IL-27 | 1.48 ± 1.46 | 0.34 ± 0.19 |
| IL-31 | 3.47 ± 4.75 | 3.43 ± 4.69 |
| IL-33 | <min | <min |
| Eotaxin | 249.84 ± 69.02 | 211.09 ± 73.41 |
| G-CSF | 44.21 ± 7.69 | 38.29 ± 13.06 |
| GM-CSF | 24.10 ± 2.72 | 19.91 ± 4.35 |
| IFN-γ | 11.03 ± 1.88 | 5.72 ± 2.02 |
| KC | 14.15 ± 1.53 | 21.39 ± 23.43 |
| CD40L | <min | <min |
| MIP-3α | 0.60 ± 0.40 | 0.87 ± 1.02 |
| MCP-1 | 85.80 ± 15.36 | 52.14 ± 13.91 |
| MIP-1α | 2.47 ± 0.50 | 1.10 ± 0.70 |
| MIP-1β | 6.42 ± 4.25 | 6.72 ± 5.09 |
| RANTES | 26.08 ± 5.76 | 17.64 ± 2.07 |
| TNF-α | 45.54 ± 10.67 | 43.07 ± 14.74 |
Figure 5The plasma treatment reactor: (a) aluminum electrode, (b) plasma discharge, (c) plasma-water surface interaction, (d) PAW.
Figure 6Lingual surface of CD1 mouse incisive (SEM). The red circle shows the area from which EDX and AFM data were collected.